NCT05389111 (UT4M2022) is a NA clinical trial of Internal discourses in Physical Exertion, sponsored by University Hospital, Grenoble.

Who is sponsoring NCT05389111?

NCT05389111 is sponsored by University Hospital, Grenoble.

What drugs are being tested in NCT05389111?

Interventions in NCT05389111: Internal discourses, Non internal discourses.

What condition does NCT05389111 study?

NCT05389111 studies Physical Exertion.

Is NCT05389111 still recruiting?

NCT05389111 is currently completed. Last updated 30 December 2025.

Last reviewed 2025-12-30 · How we verify

NCT05389111: UT4M2022

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Internal Discourses and Perception of Trail-running Effort

Completed NA Last updated 30 December 2025

What this trial tests

NA trial testing Internal discourses in Physical Exertion in 76 participants. Completed in 25 July 2025.

Timeline

15 May 2023

Primary endpoint
25 July 2025

25 July 2025

Quick facts

Lead sponsor	University Hospital, Grenoble
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	76
Start date	15 May 2023
Primary completion	25 July 2025
Estimated completion	25 July 2025
Sites	1 location across France

Drugs / interventions tested

Internal discourses
Non internal discourses

Conditions studied

Physical Exertion — all drugs for Physical Exertion →

Sponsor

University Hospital, Grenoble

Who can join

Adults 18 to 55, any sex, with Physical Exertion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Determination of the effect of an intervention to develop the use of internal discourses on the perception of exercise during a sub-maximum effort following a trail running

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Grenoble trials

Trials by the same sponsor.

NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05389111 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
Last refreshed: 30 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05389111.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing